The induction of particular brain dynamics via neural pharmacology involves the selection of particular agonists from among a class of candidate drugs and the dosing of the selected drugs according to a temporal schedule. Such a problem is made nontrivial due to the array of synergistic drugs available to practitioners whose use, in some cases, may risk the creation of dose-dependent effects that significantly deviate from the desired outcome. Here, we develop an expanded pharmacodynamic (PD) modeling paradigm and show how it can facilitate optimal construction of pharmacologic regimens, i.e., drug selection and dose schedules. The key feature of the design method is the explicit dynamical-system based modeling of how a drug binds to its molecular targets. In this framework, a particular combination of drugs creates a time-varying trajectory in a multidimensional molecular/receptor target space, subsets of which correspond to different behavioral phenotypes. By embedding this model in optimal control theory, we show how qualitatively different dosing strategies can be synthesized depending on the particular objective function considered.
Issue Section:
Technical Brief
References
1.
Chou
, T.-C.
, 2006
, “Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
,” Pharmacol. Rev.
, 58
(3
), pp. 621
–681
.2.
Campillos
, M.
, Kuhn
, M.
, Gavin
, A.-C.
, Jensen
, L. J.
, and Bork
, P.
, 2008
, “Drug Target Identification Using Side-Effect Similarity
,” Science
, 321
(5886
), pp. 263
–266
.3.
Dumont
, G. A.
, and Ansermino
, J. M.
, 2013
, “Closed-Loop Control of Anesthesia: A Primer for Anesthesiologists
,” Anesth. Analg.
, 117
(5
), pp. 1130
–1138
.4.
Syafiie
, S.
, Rami
, M. A.
, and Tadeo
, F.
, 2010
, “Positive Infusion of Propofol Drug During Induction
,” IEEE International Conference on Industrial Engineering and Engineering Management
(IEEM
), Macao, China, Dec. 7–10, pp. 325
–328
.5.
Hahn
, J.-O.
, Dumont
, G.
, and Ansermino
, J. M.
, 2011
, “Closed-Loop Anesthetic Drug Concentration Estimation Using Clinical-Effect Feedback
,” IEEE Trans. Biomed. Eng.
, 58
(1
), pp. 3
–6
.6.
Ching
, S.
, Liberman
, M. Y.
, Chemali
, J. J.
, Westover
, M. B.
, Kenny
, J. D.
, Solt
, K.
, Purdon
, P. L.
, and Brown
, E. N.
, 2013
, “Real-Time Closed-Loop Control in a Rodent Model of Medically Induced Coma Using Burst Suppression
,” Anesthesiology
, 119
(4
), pp. 848
–860
.7.
Hopkins
, A. L.
, 2008
, “Network Pharmacology: The Next Paradigm in Drug Discovery
,” Nat. Chem. Biol.
, 4
(11
), pp. 682
–690
.8.
Tang
, J.
, and Aittokallio
, T.
, 2014
, “Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles
,” Curr. Pharm. Des.
, 20
(1
), pp. 23
–36
.9.
Kirk
, D. E.
, 2004
, Optimal Control Theory: An Introduction
, Dover
, Mineola, NY
.10.
West
, N.
, Dumont
, G. A.
, van Heusden
, K.
, Petersen
, C. L.
, Khosravi
, S.
, Soltesz
, K.
, Umedaly
, A.
, Reimer
, E.
, and Ansermino
, J. M.
, 2013
, “Robust Closed-Loop Control of Induction and Maintenance of Propofol Anesthesia in Children
,” Pediatr. Anesth.
, 23
(8
), pp. 712
–719
.11.
Ingole
, D. D.
, Sonawane
, D. N.
, Naik
, V. V.
, Ginoya
, D. L.
, and Patki
, V. V.
, 2013
, “Linear Model Predictive Controller for Closed-Loop Control of Intravenous Anesthesia With Time Delay
,” ACEEE Int. J. Control Syst. Instrum.
, 4
(1
), pp. 8
–15
.12.
Shanechi
, M. M.
, Chemali
, J. J.
, Liberman
, M.
, Solt
, K.
, and Brown
, E. N.
, 2013
, “A Brain-Machine Interface for Control of Medically-Induced Coma
,” PLoS Computat. Biol.
, 9
(10
), pp. 1
–17
.13.
Derendorf
, H.
, and Meibohm
, B.
, 1999
, “Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives
,” Pharm. Res.
, 16
(2
), pp. 176
–185
.14.
Schumacher
, P. M.
, Dossche
, J.
, Mortier
, E. P.
, Luginbuehl
, M.
, Bouillon
, T. W.
, and Struys
, M. M. R. F.
, 2009
, “Response Surface Modeling of the Interaction Between Propofol and Sevoflurane
,” Anesthesiology
, 111
(4
), pp. 790
–804
.15.
Minto
, C. F.
, Schnider
, T. W.
, Short
, T. G.
, Gregg
, K. M.
, Gentilini
, A.
, and Shafer
, S. L.
, 2000
, “Response Surface Model for Anesthetic Drug Interactions
,” Anesthesiology
, 92
(6
), pp. 1603
–1616
.16.
Shaffer
, C. L.
, Osgood
, S. M.
, Smith
, D. L.
, Liu
, J.
, and Trapa
, P. E.
, 2014
, “Enhancing Ketamine Translational Pharmacology Via Receptor Occupancy Normalization
,” Neuropharmacology
, 86
, pp. 174
–180
.17.
Aradi
, I.
, and Erdi
, P.
, 2006
, “Computational Neuropharmacology: Dynamical Approaches in Drug Discovery
,” Trends Pharmacol. Sci.
, 27
(5
), pp. 240
–243
.18.
Ching
, S.
, and Brown
, E. N.
, 2014
, “Modeling the Dynamical Effects of Anesthesia on Brain Circuits
,” Curr. Opin. Neurobiol.
, 25
, pp. 116
–122
.19.
Brown
, E. N.
, Purdon
, P. L.
, and Van Dort
, C. J.
, 2011
, “General Anesthesia and Altered States of Arousal: A Systems Neuroscience Analysis
,” Annu. Rev. Neurosci.
, 34
(1
), pp. 601
–628
.20.
Ching
, S.
, Cimenser
, A.
, Purdon
, P. L.
, Brown
, E. N.
, and Kopell
, N. J.
, 2010
, “Thalamocortical Model for a Propofol-Induced Alpha-Rhythm Associated With Loss of Consciousness
,” Proc. Natl. Acad. Sci. U.S.A.
, 107
(52
), pp. 22665
–22670
.21.
Vijayan
, S.
, Ching
, S.
, Purdon
, P. L.
, Brown
, E. N.
, and Kopell
, N. J.
, 2013
, “Thalamocortical Mechanisms for the Anteriorization of α Rhythms During Propofol-Induced Unconsciousness
,” J. Neurosci.
, 33
(27
), pp. 11070
–11075
.22.
Trescot
, A. M.
, Datta
, S.
, Lee
, M.
, and Hansen
, H.
, 2008
, “Opioid Pharmacology
,” Pain Physician
, 11
(Suppl. 2
), pp. S133
–S153
.23.
Holz
, M.
, and Fahr
, A.
, 2001
, “Compartment Modeling
,” Adv. Drug Delivery Rev.
, 48
(2–3
), pp. 249
–264
.24.
Haddad
, W. M.
, Chellaboina
, V.
, and Hui
, Q.
, 2010
, Nonnegative and Compartmental Dynamical Systems
, Princeton University Press
, Princeton, NJ
.25.
Danhof
, M.
, de Jongh
, J.
, Lange
, E. C. D.
, Pasqua
, O. D.
, Ploeger
, B. A.
, and Voskuyl
, R. A.
, 2007
, “Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling: Biophase Distribution, Receptor Theory, and Dynamical Systems Analysis
,” Annu. Rev. Pharmacol. Toxicol.
, 47
(1
), pp. 357
–400
.26.
Schuler
, S.
, Ebenbauer
, C.
, and Allgöwer
, F.
, 2011
, “L0-System Gain and l1-Optimal Control
,” 18th IFAC World Congress
, Milan, Italy, Aug. 28–Sept. 2, Vol. 18
, pp. 9230
–9235
.27.
Gallieri
, M.
, and Maciejowski
, J. M.
, 2012
, “ℓ asso MPC: Smart Regulation of Over-Actuated Systems
,” American Control Conference
(ACC
), Montreal, Canada, June 27–29, pp. 1217
–1222
.28.
Nagahara
, M.
, Quevedo
, D. E.
, and Nesic
, D.
, 2013
, “Maximum Hands-Off Control and L1 Optimality
,” IEEE 52nd Annual Conference on Decision and Control
(CDC
), Firenze, Italy, Dec. 10–13, pp. 3825
–3830
.29.
Kwon
, W. H.
, and Han
, S. H.
, 2005
, “Receding Horizon Control: Model Predictive Control for State Models
,” Advanced Textbooks in Control and Signal Processing
, Springer
, London
.30.
Mayne
, D. Q.
, Rawlings
, J. B.
, Rao
, C. V.
, and Scokaert
, P. O. M.
, 2000
, “Constrained Model Predictive Control: Stability and Optimality
,” Automatica
, 36
(6
), pp. 789
–814
.31.
Qin
, S.
, and Badgwell
, T. A.
, 2003
, “A Survey of Industrial Model Predictive Control Technology
,” Control Eng. Pract.
, 11
(7
), pp. 733
–764
.32.
Sawaguchi
, Y.
, Furutani
, E.
, Shirakanmi
, G.
, Araki
, M.
, and Fukuda
, K.
, 2003
, “A Model-Predictive Hypnosis Control System Under Total Intravenous Anesthesia
,” IEEE Trans. Biomed. Eng.
, 55
(3
), pp. 874
–887
.33.
Luginbühl
, M.
, Bieniok
, C.
, Leibundgut
, D.
, Wymann
, R.
, Gentilini
, A.
, and Schnider
, T. W.
, 2006
, “Closed-Loop Control of Mean Arterial Blood Pressure During Surgery With Alfentanil: Clinical Evaluation of a Novel Model-Based Predictive Controller
,” Anesthesiology
, 105
(3
), pp. 462
–470
.34.
Hovorka
, R.
, 2011
, “Closed-Loop Insulin Delivery: From Bench to Clinical Practice
,” Nat. Rev. Endocrinol.
, 7
(7
), pp. 385
–395
.35.
Maguire
, P.
, Tsai
, N.
, Kamal
, J.
, Cometta-Morini
, C.
, Upton
, C.
, and Loew
, G.
, 1992
, “Pharmacological Profiles of Fentanyl Analogs at Mu, Delta and Kappa Opiate Receptors
,” Eur. J. Pharmacol.
, 213
(2
), pp. 219
–225
.36.
McCarthy
, M. M.
, Brown
, E. N.
, and Kopell
, N.
, 2008
, “Potential Network Mechanisms Mediating Electroencephalographic Beta Rhythm Changes During Propofol-Induced Paradoxical Excitation
,” J. Neurosci.
, 28
(50
), pp. 13488
–13504
.37.
Eghbali
, M.
, Gage
, P. W.
, and Birnir
, B.
, 2003
, “Effects of Propofol on GABAa Channel Conductance in Rat-Cultured Hippocampal Neurons
,” Eur. J. Pharmacol.
, 468
(2
), pp. 75
–82
.38.
Jin
, Y.-H.
, Zhang
, Z.
, Mendelowitz
, D.
, and Andresen
, M. C.
, 2009
, “Presynaptic Actions of Propofol Enhance Inhibitory Synaptic Transmission in Isolated Solitary Tract Nucleus Neurons
,” Brain Res.
, 1286
, pp. 75
–83
.39.
Yildirim
, M. A.
, Goh
, K.-I.
, Cusick
, M. E.
, Barabási
, A.-L.
, and Vidal
, M.
, 2007
, “Drug-Target Network
,” Nat. Biotechnol.
, 25
(10
), pp. 1119
–1126
.40.
Kern
, S. E.
, and Stanski
, D. R.
, 2008
, “Pharmacokinetics and Pharmacodynamics of Intravenously Administered Anesthetic Drugs: Concepts and Lessons for Drug Development
,” Clin. Pharmacol. Ther.
, 84
(1
), pp. 153
–156
.41.
Absalom
, A. R.
, Mani
, V.
, De Smet
, T.
, and Struys
, M. M. R. F.
, 2009
, “Pharmacokinetic Models for Propofol—Defining and Illuminating the Devil in the Detail
,” Br. J. Anaesth.
, 103
(1
), pp. 26
–37
.42.
Bai
, D.
, Pennefather
, P. S.
, MacDonald
, J. F.
, and Orser
, B. A.
, 1999
, “The General Anesthetic Propofol Slows Deactivation and Desensitization of GABAa Receptors
,” J. Neurosci.
, 19
(24
), pp. 10635
–10646
.Copyright © 2016 by ASME
You do not currently have access to this content.
